oSIST prEN 16777:2014

Chemical disinfectants and antiseptics - Quantitative non-porous surface test without mechanical action for the evaluation of virucidal activity of chemical disinfectants used in the medical area - Test method and requirements (phase 2/step 2)

This European Standard specifies a test method and the minimum requirements for virucidal activity of chemical disinfectants that form a homogeneous physically stable preparation when diluted with hard water - or in the case of ready-to-use products - with water.
This European Standard applies to products that are used in the medical area for disinfecting non-porous surfaces including surfaces of medical devices without mechanical action.
This European Standard applies to areas and situations where disinfection is medically indicated. Such indications occur in patient care, for example:
- in hospitals, in community medical facilities, and in dental institutions;
- in clinics of schools, of kindergartens, and of nursing homes;
and may occur in the workplace and in the home.
It may also include services such as laundries and kitchens supplying products directly for the patients.
NOTE 1 The method described is intended to determine the activity of commercial formulations or active substances on viruses in the conditions in which they are used.
NOTE 2 This method corresponds to a phase 2, step 2 test.
EN 14885 specifies in detail the relationship of the various tests to one another and to 'use recommendations'.

Chemische Desinfektionsmittel und Antiseptika - Quantitativer Versuch auf nicht porösen Oberflächen ohne mechanische Einwirkung zur Bestimmung der viruziden Wirkung im humanmedizinischen Bereich - Prüfverfahren und Anforderungen (Phase 2, Stufe 2)

Diese Europäische Norm legt ein Prüfverfahren für und die Mindestanforderungen an die viruzide Wirkung von chemischen Desinfektionsmitteln fest, die bei Verdünnung mit Wasser standardisierter Härte als homogene, physikalisch stabile Zubereitung vorliegen, bzw. bei gebrauchsfertigen Produkten bei Verdünnung mit Wasser.
Diese Europäische Norm gilt für Produkte, die im medizinischen Bereich zur Desinfektion von nicht porösen Oberflächen, einschließlich Oberflächen auf Medizinprodukten, ohne mechanische Einwirkung verwendet werden.
Diese Europäische Norm gilt für Bereiche und unter Bedingungen, wo eine Desinfektion aus medizinischen Gründen angezeigt ist. Indikationen dieser Art liegen z. B. vor bei der Patientenbetreuung:
   in Krankenhäusern, kommunalen medizinischen Einrichtungen und im Dentalbereich;
   in medizinischen Bereichen in Schulen, Kindergärten und Heimen
und können auch am Arbeitsplatz oder im privaten Bereich gegeben sein.
Eingeschlossen sein können auch Einrichtungen wie Wäschereien und Küchen, die der direkten Versorgung von Patienten dienen.
ANMERKUNG 1   Das beschriebene Verfahren dient zur Bestimmung der Wirkung handelsüblicher Zubereitungen oder Wirkstoffe auf Viren unter den Bedingungen, unter denen sie angewendet werden.
ANMERKUNG 2   Dieses Verfahren entspricht einer Prüfung der Phase 2, Stufe 2.
EN 14885 legt im Einzelnen die Beziehung der verschiedenen Prüfungen untereinander sowie zu den „Anwendungsempfehlungen“ fest.

Antiseptiques et désinfectants chimiques - Essai quantitatif de surface non-poreuse sans action mécanique pour l'évaluation de l'activité virucide des désinfectants chimiques utilisés dans le domaine médical - Méthode d'essai et prescriptions (phase 2/étape 2)

La présente Norme européenne décrit une méthode d’essai et les prescriptions minimales relatives à l’activité virucide des désinfectants chimiques qui forment une préparation homogène, physiquement stable, lorsqu’ils sont dilués dans de l'eau dure ou – dans le cas de produits prêts à l’emploi – dans l’eau.
La présente Norme européenne s'applique aux produits utilisés en médecine humaine pour la désinfection des surfaces non poreuses, y compris les surfaces des dispositifs médicaux, sans action mécanique.
La présente Norme européenne s'applique dans les domaines et situations où la désinfection est indiquée en médecine humaine. De telles indications se rencontrent dans le cadre des soins apportés aux patients, par exemple :
-   dans des hôpitaux, dans des centres de soins médicaux et des cabinets dentaires ;
-   dans des infirmeries d’écoles, de jardins d’enfants et de maisons de retraite ;
et peuvent aussi se rencontrer sur les lieux de travail ou à domicile.
Elles peuvent également concerner des services tels que des blanchisseries et des cuisines qui fournissent des produits directement aux patients.
NOTE 1   La méthode décrite vise à déterminer l’activité des formulations commerciales ou des substances actives sur les virus dans les conditions dans lesquelles elles sont utilisées.
NOTE 2   Cette méthode correspond à un essai de phase 2, étape 2.
L'EN 14885 spécifie de façon détaillée les relations des différents essais entre eux et avec les « recommandations d’emploi ».

Kemična razkužila in antiseptiki - Kvantitativni preskus na neporoznih površinah brez mehanskega delovanja za vrednotenje virucidnega delovanja kemičnih razkužil, ki se uporabljajo v humani medicini - Preskusna metoda in zahteve (faza 2/stopnja 2)

General Information

• Status: Not Published
• Public Enquiry End Date: 05-Nov-2014
• ICS: 11.080.20 - Disinfectants and antiseptics
• Technical Committee: KDS - Cosmetics, chemical disinfectants and surface active agents
• Current Stage: 98 - Abandoned project (Adopted Project)
• Start Date: 08-Dec-2016
• Due Date: 13-Dec-2016
• Completion Date: 08-Dec-2016
• Directive: 93/42/EEC - Council Directive 93/42/EEC of 14 June 1993 concerning medical devices
• Mandate: M/BC/CEN/89/9 - Joint Standardization request to CEN/CENELEC concerning harmonized standards relating to horizontal aspects in the field of medical devices
• Ref Project: FprEN 16777 - Chemical disinfectants and antiseptics - Quantitative non-porous surface test without mechanical action for the evaluation of virucidal activity of chemical disinfectants used in the medical area - Test method and requirements (phase 2/step 2)

Relations

• Revised: SIST EN 16777:2019 - Chemical disinfectants and antiseptics - Quantitative non-porous surface test without mechanical action for the evaluation of virucidal activity of chemical disinfectants used in the medical area - Test method and requirements (phase 2/step 2)
• Effective Date: 01-Feb-2019

Standards Content (Sample)

SLOVENSKI STANDARD
oSIST prEN 16777:2014
01-oktober-2014
.HPLþQDUD]NXåLODLQDQWLVHSWLNL.YDQWLWDWLYQLSUHVNXVQDQHSRUR]QLKSRYUãLQDK
EUH]PHKDQVNHJDGHORYDQMD]DYUHGQRWHQMHYLUXFLGQHJDGHORYDQMDNHPLþQLK
UD]NXåLONLVHXSRUDEOMDMRYKXPDQLPHGLFLQL3UHVNXVQDPHWRGDLQ]DKWHYHID]D
VWRSQMD
Chemical disinfectants and antiseptics - Quantitative non-porous surface test without
mechanical action for the evaluation of virucidal activity of chemical disinfectants used in
the medical area - Test method and requirements (phase 2/step 2)
Chemische Desinfektionsmittel und Antiseptika - Quantitativer Versuch auf nicht porösen
Oberflächen ohne mechanische Einwirkung zur Bestimmung der viruziden Wirkung im
humanmedizinischen Bereich - Prüfverfahren und Anforderungen (Phase 2, Stufe 2)
Antiseptiques et désinfectants chimiques - Essai quantitatif de surface non-poreuse sans
action mécanique pour l'évaluation de l'activité virucide des désinfectants chimiques
utilisés dans le domaine médical - Méthode d'essai et prescriptions (phase 2/étape 2)
Ta slovenski standard je istoveten z: prEN 16777
ICS:
11.080.20 Dezinfektanti in antiseptiki Disinfectants and antiseptics
oSIST prEN 16777:2014 en,fr,de
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

---------------------- Page: 1 ----------------------
oSIST prEN 16777:2014

---------------------- Page: 2 ----------------------
oSIST prEN 16777:2014

EUROPEAN STANDARD
DRAFT
prEN 16777
NORME EUROPÉENNE

EUROPÄISCHE NORM

July 2014
ICS 11.080.20
English Version
Chemical disinfectants and antiseptics - Quantitative non-porous
surface test without mechanical action for the evaluation of
virucidal activity of chemical disinfectants used in the medical
area - Test method and requirements (phase 2/step 2)
Antiseptiques et désinfectants chimiques - Essai quantitatif Chemische Desinfektionsmittel und Antiseptika -
de surface non-poreuse sans action mécanique pour Quantitativer Versuch auf nicht porösen Oberflächen ohne
l'évaluation de l'activité virucide des désinfectants mechanische Einwirkung zur Bestimmung der viruziden
chimiques utilisés dans le domaine médical - Méthode Wirkung im humanmedizinischen Bereich - Prüfverfahren
d'essai et prescriptions (phase 2/étape 2) und Anforderungen (Phase 2, Stufe 2)
This draft European Standard is submitted to CEN members for enquiry. It has been drawn up by the Technical Committee CEN/TC 216.

If this draft becomes a European Standard, CEN members are bound to comply with the CEN/CENELEC Internal Regulations which
stipulate the conditions for giving this European Standard the status of a national standard without any alteration.

This draft European Standard was established by CEN in three official versions (English, French, German). A version in any other language
made by translation under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United
Kingdom.

Recipients of this draft are invited to submit, with their comments, notification of any relevant patent rights of which they are aware and to
provide supporting documentation.

Warning : This document is not a European Standard. It is distributed for review and comments. It is subject to change without notice and
shall not be referred to as a European Standard.


EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION

EUROPÄISCHES KOMITEE FÜR NORMUNG

CEN-CENELEC Management Centre: Avenue Marnix 17, B-1000 Brussels
© 2014 CEN All rights of exploitation in any form and by any means reserved Ref. No. prEN 16777:2014 E
worldwide for CEN national Members.

---------------------- Page: 3 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
Contents
Page
Foreword .3
Introduction .4
1 Scope .5
2 Normative references .5
3 Terms and definitions .5
4 Requirements for virucidal activity on surfaces .6
5 Test methods .6
5.1 Principle .6
5.2 Materials and reagents, including cell cultures .7
5.3 Apparatus and glassware . 10
5.4 Preparation of test organism suspensions and product test solutions . 12
5.5 Procedure for assessing the virucidal activity of the product . 13
5.6 Experimental data and calculation. 17
5.7 Verification of the methodology . 18
5.8 Expression of results . 19
5.9 Test report . 19
Annex A (informative) Examples of viruses sorted according to their presence in the human
body in case of virus infection . 21
Annex B (normative) Detoxification of test mixtures by molecular sieving . 23
B.1 Molecular sieving with SephadexTM LH 20 . 23
Annex C (informative) Calculation of the viral infectivity titre . 25
C.1 Quantal tests . 25
C.2 Plaque test . 26
C.3 Biometrical evaluation of experimental approaches and assessment of the disinfecting
effect on the virus (reduction [R]): . 26
Bibliography . 31


2

---------------------- Page: 4 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
Foreword
This document (prEN 16777:2014) has been prepared by Technical Committee CEN/TC 216 “Chemical
disinfectants and antiseptics”, the secretariat of which is held by AFNOR.
This document is currently submitted to the CEN Enquiry.
3

---------------------- Page: 5 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
Introduction
This European Standard describes a surface test method for establishing whether a product proposed as
a disinfectant in the fields described in clause 1 has or does not have virucidal activity on non-porous
surfaces.
The laboratory test closely simulates practical conditions of application. Chosen conditions (contact time,
temperature, organisms on surfaces etc.) reflect parameters which are found in practical situations including
conditions which may influence the action of disinfectants. Each use concentration found from this test
corresponds to defined experimental conditions.
The conditions are intended to cover general purposes and to allow reference between laboratories and
product types. Each utilization concentration of the chemical disinfectant or antiseptic found by this test
corresponds to defined experimental conditions.
However for special applications the recommendations of use of a product can differ and therefore additional
test conditions might be needed, which cannot be covered by this European Standard.
4

---------------------- Page: 6 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
1 Scope
This European Standard specifies a test method and the minimum requirements for virucidal activity of
chemical disinfectants that form a homogeneous physically stable preparation when diluted with hard water –
or in the case of ready-to-use products - with water.
This European Standard applies to products that are used in the medical area for disinfecting non-porous
surfaces including surfaces of medical devices without mechanical action.
This European Standard applies to areas and situations where disinfection is medically indicated. Such
indications occur in patient care, for example:
 in hospitals, in community medical facilities, and in dental institutions;
 in clinics of schools, of kindergartens, and of nursing homes;
and may occur in the workplace and in the home.
It may also include services such as laundries and kitchens supplying products directly for the patients.
NOTE 1 The method described is intended to determine the activity of commercial formulations or active substances
on viruses in the conditions in which they are used.
NOTE 2 This method corresponds to a phase 2, step 2 test.
EN 14885 specifies in detail the relationship of the various tests to one another and to “use
recommendations”.
2 Normative references
The following documents, in whole or in part, are normatively referenced in this document and are
indispensable for its application. For dated references, only the edition cited applies. For undated references,
the latest edition of the referenced document (including any amendments) applies.
EN 14476, Chemical disinfectants and antiseptics — Quantitative suspension test for the evaluation of
virucidal activity in the medical area — Test method and requirements (Phase 2/Step 1).
EN 12353, Chemical disinfectants and antiseptics — Preservation of test organisms used for the
determination of bactericidal (including Legionella), mycobactericidal, sporicidal, fungicidal and virucidal
(including bacteriophages) activity
EN 14885, Chemical disinfectants and antiseptics — Application of European Standards for chemical
disinfectants and antiseptics.
EN 10088-1, Stainless steels - Part 1: List of stainless steels.
EN 10088-2, Stainless steels - Part 2: Technical delivery conditions for sheet/plate and strip of corrosion
resisting steels for general purposes.
3 Terms and definitions
For the purposes of this document, the terms and definitions given in EN 14885 and EN 14476 apply.
5

---------------------- Page: 7 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
4 Requirements for virucidal activity on surfaces
The product shall demonstrate at least a decimal log (lg) reduction of 4 in virus titre of the Adenovirus and
Murine Norovirus test strains when tested in accordance with table 1 and Clauses 5, 6, 7, 8, and 9.
Table 1 — Minimum and additional test conditions
Test conditions
Test virus Adenovirus Type 5
Murine Norovirus
Test temperature between 18 °C ± 1 °C and 25 °C ± 1 °C
Contact time according to the manufacturer’s recommendation, but not longer than 5
a
min or 60 min
Interfering substances
a) clean 0,3 g/l bovine serum albumin
and/or
b) dirty 3,0 g/l bovine serum albumin plus 3,0 ml erythrocytes
b Further contact time(s), interfering substance(s) or virus(es)
Additional conditions
a
The contact times for surface disinfectants stated in this table are chosen on the basis of the practical conditions of
the product. The recommended contact time for the use of the product is within the responsibility of the manufacturer.
Products intended to disinfect surfaces that are likely to come into contact with the patient and / or the medical staff and
surfaces, which are frequently touched by different people, leading to the transmission of microorganisms to the patient,
shall be tested with a contact time of maximum 5 min. The same applies where the contact time of the product shall be
limited for practical reasons. Products for other surfaces than stated above may be tested with a contact time of
maximum 60 min.
b
Where appropriate (specific purposes), additional specific virucidal activity shall be determined under other conditions
of time, temperature, and interfering substances (see 5.2.3.3) in accordance with 6.2, in order to take into account
intended specific use conditions. Additional virus(es) can be tested, if relevant.

The determined virucidal concentration of the test product is suggested as being suitable for practical
situations of use.
5 Test methods
5.1 Principle
5.1.1 A test suspension of viruses in a solution of interfering substances is inoculated onto a test stainless
steel disc and dried. A prepared sample of the product under test is applied in a manner which covers the
dried film.
The disc is maintained at a specified temperature for a defined period of time. The disc is transferred to cell
maintenance medium so that the action of the disinfectant is immediately neutralised. The titre of the virus
recovered from the disc is determined.
The titre of the virus on a disc treated with hard water in place of the disinfectant is also determined and the
reduction in virus titre attributed to the product is calculated by difference.
5.1.2 The test is performed using the test organisms as specified in clause 4, table 1.
5.1.3 Other contact times and temperatures within the limits specified in clause 4, table 1 may be used.
Additional interfering substances and test organisms may be used.
6

---------------------- Page: 8 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
5.2 Materials and reagents, including cell cultures
5.2.1 Test organisms
The virucidal activity shall be evaluated using the following strains as test organisms selected according to
1)
clause 4, table 1
2)
a) Non-enveloped RNA virus
Murine norovirus, strain S99 Berlin
b) Non-enveloped DNA virus
Adenovirus type 5, strain Adenoid 75, ATCC VR-5*
The required incubation temperature for these test organisms is 36 °C ± 1 °C or 37 °C ± 1 °C (5.3.2.3). The
same temperature (either 36 °C or 37 °C) shall be used for all incubations performed during a test and its
control and validation.
If additional test organisms are used, they shall be kept and used under optimum growth conditions
(temperature, time, atmosphere, media) noted in the test report. If these additional test organisms are not
classified at a reference centre, their identification characteristics shall be stated. In addition, they shall be
held by the testing laboratory or national culture collection under a reference for five years.
5.2.2 Culture media, reagents and cell cultures
5.2.2.1 General
All weights of chemical substances given in this European Standard refer to the anhydrous salts. Hydrated
forms may be used as an alternative, but the weights required shall be adjusted to allow for consequent
molecular weight differences.
The reagents shall be of analytical grade and/or appropriate for microbiological purposes. They shall be free
from substances that are toxic or inhibitory to the test organisms.
To improve reproducibility, it is recommended that commercially available – if appropriate the material is used
for the preparation of culture media. The manufacturer's instructions relating to the preparation of these
products should be rigorously followed.
For each culture medium and reagent, a time limitation for use should be fixed.
All specified pH values are measured at 20 °C ± 1 °C.
5.2.2.2 Water
The water shall be freshly glass-distilled water and not demineralized water. If distilled water of adequate
quality is not available, water for injections (see bibliographic reference [1]) may be used.
Sterilize in the autoclave [5.3.2.1a)]. Sterilization is not necessary if the water is used e.g. for preparation of
culture media and subsequently sterilized.
See 5.2.2.7 for the procedure to prepare hard water.

1) The ATCC numbers are the collection numbers of strains supplied by these culture collections. This information is
given for the convenience of users of this European Standard and does not constitute an endorsement by CEN of the
product named.
2) Virus strains may be obtained from a national or international culture collection. Murine Norovirus may be obtained
from Friedrich-Loeffler-Insitut Bundesforschunsinstitut für Tiergesundheit, Hauptsitz Insel Riems Südufer 10, 17493,
Greifswald-Insel Riems; phone: [phone], fax: [phone]. http://www.fli.bund.de.
7

---------------------- Page: 9 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
5.2.2.3 Phosphate buffered saline (PBS)
Sodium chloride (NaCl) 8,00 g
Potassium chloride (KCl) 0,20 g
Disodium hydrogen phosphate, 12-hydrate (Na HPO x 12H O) 2,89 g
2 4 2
Potassium phosphate, monobasic (KH PO ) 0,20 g
2 4
Water (5.2.2.2) to 1000,0 ml
5.2.2.4 Neutral Red (1:1000 solution)
Prepare neutral red (Sigma N7005) stock solution at 0,1 mg/ml in water (5.2.2.2). Filter through a 0,40 µm
pore size filter and store 4 °C in the dark.
5.2.2.5 Foetal calf serum (FCS)
FCS has to be certified free of viruses and mycoplasma. Extraneous viruses and mycoplasma may interfere
with cell and virus growth resulting in false results.
For RAW 264.7 cells, special FCS has to be used due to the cells’ high sensitivity to endotoxins.
5.2.2.6 Trichloroacetic acid (10% solution) (TCA)
Dissolve 10 g of TCA crystals in 80 ml of water (5.2.2.2), and then adjust the volume to 100 ml with water. Stir
to complete solution.
5.2.2.7 Hard water for dilution of products
For the preparation of 1 l of hard water, the procedure is as follows:
 prepare solution A: dissolve 19,84 g magnesium chloride (MgCl ) and 46,24 g calcium chloride (CaCl ) in
2
2
water (5.2.2.2) and dilute to 1 000 ml. Sterilize by membrane filtration (5.3.2.7) or in the autoclave
[5.3.2.1 a)]. Autoclaving – if used - may cause a loss of liquid. In this case make up to 1 000 ml with water
(5.2.2.2) under aseptic conditions. Store the solution in the refrigerator (5.3.2.8) for no longer than one
month;
 prepare solution B: dissolve 35,02 g sodium bicarbonate (NaHCO ) in water (5.2.2.2) and dilute to
3
1000 ml. Sterilize by membrane filtration (5.3.2.7). Store the solution in the refrigerator (5.3.2.8) for no
longer than one week;
 place 600 ml to 700 ml of water (5.2.2.2) in a 1000 ml volumetric flask (5.3.2.12) and add 6,0 ml (5.3.2.9)
of solution A, then 8,0 ml of solution B. Mix and dilute to 1000 ml with water (5.2.2.2). The pH (5.3.2.4) of
the hard water shall be 7,0 ± 0,2. (5.3.2.4). If necessary, adjust the pH by using a solution of
approximately 40 g/l (about 1 mol/l) of sodium hydroxide (NaOH) or approximately 36,5 g/l (about 1 mol/l)
of hydrochloric acid (HCl).
The hard water shall be freshly prepared under aseptic conditions and used within 12 h.
NOTE When preparing the product test solutions (5.4.2), the addition of the product to the hard water produces
different final water hardness in each test tube. In any case, the final hardness in the test tube expressed as calcium
carbonate (CaCO ) is lower than 375 mg/l.
3
8

---------------------- Page: 10 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
5.2.2.8 Interfering substance
5.2.2.8.1 General
The interfering substance shall be chosen according to the conditions of use laid down for the product.
The interfering substance shall be sterile and prepared at 10 times its final concentration in the test.
The ionic composition (e.g. pH, calcium and/or magnesium hardness) and chemical composition (e.g. mineral
substances, protein, carbohydrates, lipids and detergents) shall be defined.
“Diluent” is generally used in the other European Standards in the medical area to prepare the interfering
substance. Since there is no experience in virucidal testing with diluent, water (5.2.2.2) is used instead.
NOTE The term “interfering substance” is used even if it contains more than one substance.
5.2.2.8.2 Clean conditions (bovine serum albumin)
Bovine serum albumin shall be used as commercially available product or shall be prepared as follows:
 dissolve 0,3 g of bovine albumin fraction V (suitable for microbiological purposes) in 100 ml of water
(5.2.2.2);
 sterilize by membrane filtration;
 keep in a refrigerator and use within one month.
The final concentration of bovine serum albumin (BSA) in the test is 0,3 g BSA per litre.
5.2.2.8.3 Dirty conditions
a) bovine serum albumin:
Bovine serum albumin shall be used as commercially available product or shall be prepared as follows:
 dissolve 3 g of bovine albumin fraction V (suitable for microbiological purposes) in 100 ml of water
(see 5.2.2.2);
 sterilize by membrane filtration;
 keep in a refrigerator and use within one month.
The final concentration of bovine serum albumin (BSA) in the control is 3 g BSA per litre (see 6.6.3).
b) sheep erthrocytes:
Prepare at least 8,0 ml fresh defibrinated sheep blood (5.2.2.9). Centrifuge the erythrocytes at 800 g for
N
10 min (5.3.2.13). After discarding the supernatant, resuspend erythrocytes in water (5.2.2.2). Repeat this
procedure at least 3 times, until the supernatant is colourless.
c) bovine albumin and erythrocyte solution:
Resuspend 3 ml of packed erythrocytes with 97 ml of 3 % w/v of bovine albumin solution.
The final concentration of sheep erythrocytes and albumin in the test procedure is 3 ml/l and 3 g/l respectively.
To avoid contamination this mixture shall be split in portions probably needed per day and stored in separate
containers for a maximum of 7 days at 2 °C to 8 °C.
9

---------------------- Page: 11 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
5.2.2.9 Defibrinated sheep blood
The defibrinated sheep blood shall be sterile (aseptic blood-letting and preparation). The defibrinated sheep
blood can be pooled from more than one sheep and can be acquired from a commercial supplier.
5.2.2.10 Medium for cell cultures
Eagle’s minimal essential medium (MEM) or equivalent, supplemented with FCS (5.2.2.5), antibiotics, and
other growth factors as needed shall be used.
a) A growth medium for cell multiplication is supplemented with 10% FCS. Add 10 parts of FCS (5.2.2.5) to
90 parts of MEM.
b) A maintenance medium to maintain the cell culture metabolism without stimulation of cell proliferation is
supplemented with 2% FCS. Add 2 parts of FCS (5.2.2.5) to 98 parts of MEM.
Other media may be used if appropriate for certain cell lines.
See also bibliographic reference [2]. See EN 12353 for a detailed description.
5.2.2.11 Cell cultures
Cell monolayers shall be >90% confluent before inoculation. Cell lines are selected in accordance with their
sensitivity to the test organisms (5.2.1). Cells for virus titration, if used as suspensions in quantal tests, shall
be added to the dilutions of the test mixture (5.5.2) in such a density as to enable the formation of a monolayer
in at least two days in the cell control. Cell cultures can be used as cell monolayers or in suspensions for
quantal tests. For details of cell lines see 5.5.1.1e).
5.3 Apparatus and glassware
5.3.1 General
Sterilize all glassware and parts of the apparatus that will come into contact with the culture media and
reagents or the sample, except those which are supplied sterile, by one of the following methods:
c) by moist heat, in the autoclave [5.3.2.1 a)];
d) by dry heat, in the hot air oven [5.3.2.1 b)].
3)
5.3.2 Usual microbiological laboratory equipment
And, in particular, the following:
5.3.2.1 Apparatus for sterilization (moist and dry heat)
+3
e) For moist heat sterilization, an autoclave capable of being maintained at (121 ) °C for a minimum
0
holding time of 15 min;
+5
f) for dry heat sterilization, a hot air oven capable of being maintained at (180 ) °C for a minimum holding
0
+5 +5
time of 30 min, at (170 ) °C for a minimum holding time of 1 h or at (160 ) °C for a minimum holding
0 0
time of 2 h.
5.3.2.2 Water baths, capable of being controlled at 20 °C ± 1 °C, and at additional test temperatures
± 1 °C (5.5.1).

3) Disposable sterile equipment is an acceptable alternative to reusable glassware.
10

---------------------- Page: 12 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
5.3.2.3 Inverted microscope for reading cell cultures microscopically
5.3.2.4 pH meter, having an accuracy of calibration of 0,1 pH units at 20 °C.
5.3.2.5 Stopwatch
5.3.2.6 Refrigerator, capable of being controlled at 2 °C to 8 °C.
4)
5.3.2.7 Electromechanical agitator e.g. Vortex ® mixer
5.3.2.8 Containers: Petri plates, sterile test tubes, culture bottles or flasks of suitable capacity.
5.3.2.9 Volumetric flasks, calibrated at 20°C.
5.3.2.10 Sterile microtitre plates, six well plates for cell culture, and flasks for cell culture use.
5.3.2.11 Membrane filtration apparatus for filtration of media, 0,2 μm pore size
5.3.2.12 CO incubator (95% air, 5% CO ), capable of being controlled at 36 °C ± 1 °C, for incubation of
2 2
cell cultures. An incubator at 37 °C ± 1 °C may be used if an incubator at 36 °C ± 1 C is not available.
5.3.2.13 Graduated sterile pipettes of nominal capacities 10 ml and 1 ml and 0,1 ml.
NOTE Calibrated automatic pipettes may be used.
5.3.2.14 Magnetic stirrer for keeping cells in suspension before seeding
5.3.2.15 Ice producing machine or commercially available ice to cool the cell maintenance medium
and the reaction mixtures during the test (see 6.1, 6.5.1, and 6.6.3)
5.3.2.16 Basin as ice bath with ice and water
5.3.2.17 Mechanical shaker
5.3.2.18 Centrifuge
5.3.2.19 Biological safety cabinet, class II
5.3.2.20 Freezer, -70 °C
5.3.2.21 Desiccator with vacuum manometer
3
5.3.2.22 Vacuum Diaphragm Pump (throughput max. 3,8 m /h final vacuum < 75mbar)
5.3.3 Test surfaces
These shall be 1.4301 (EN 10088-1) stainless steel discs (2 cm diameter discs) with Grade 2 B finish on both
sides, in accordance with the requirements of EN 10088-2. The discs shall be as flat as possible and this is
best achieved by using stainless steel of a gauge of 1,2 mm or 1,5 mm. The discs shall be handled only with
forceps and used only once.
®,
Prior to use the discs shall be placed in a container with an appropriate quantity of 5 % (V/V) Decon 90 or of
5)
1% Blanisol-Pur for 60 min, in a manner that they don’t stick together and the surface is not damaged.

4) Vortex ® is an example of a suitable product available commercially. This information is given for the convenience of
users of this document and does not constitute an endorsement by CEN of this product
®
5) Decon 90 and Blanisol-Pur are examples of suitable products available commercially. This information is given for
the convenience of users of this standard and does not constitute an endorsement by CEN of those products.
11

---------------------- Page: 13 ----------------------
oSIST prEN 16777:2014
prEN 16777:2014 (E)
Rinse the discs with running freshly distilled water (5.2.2.2) or demineralised water for 10 s, avoiding them to
dry at any extent.
Rinse the discs with water (5.2.2.2) for a further 10 s to ensure complete removal of the surfactant. To supply
a satisfactory flow of water, a sterilized fluid dispensing pressure vessel with suitable hose and connectors or
other suitable method can be used and regulated to supply approximately 2000 ml per min. Dip the disc in a
bath containing 70 % (V/V) ethanol for 15 min. Remove the discs and rinse them with double distilled water for
at least 10 seconds. Sterilize by autoclaving.
NOTE Suitable stainless steel discs can usually be purchased from local engineering companies.
5.4 Preparation of test organism suspensions and product test solutions
5.4.1 Test organisms suspensions (test virus suspension)
The test organisms and their stock cultures shall be prepared and kept in accordance with EN 12353.
The stock virus suspension is multiplied in an appropriate cell line that produces high titres of infectious
viruses. The cell debris is
...